KCA
Search
- Page Path
- HOME > Search
Original Article
- Breast cancer
- Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy
- Dowook Kim, Jin Ho Kim, In Ah Kim, Ji Hyun Chang, Kyung Hwan Shin
- Cancer Res Treat. 2023;55(2):592-602. Published online October 11, 2022
- DOI: https://doi.org/10.4143/crt.2022.998
-
Abstract
PDF
Supplementary Material
PubReader
ePub - Purpose
The utility of postmastectomy radiation therapy (PMRT) for breast cancer patients after neoadjuvant chemotherapy (NAC) is highly controversial. This study evaluated the impact of PMRT according to pathologic nodal status after modern NAC.
Materials and Methods
We retrospectively reviewed 682 patients with clinical stage II-III breast cancer who underwent NAC and mastectomy from 2013 to 2017. In total, 596 patients (87.4%) received PMRT, and 86 (12.6%) did not. We investigated the relationships among locoregional recurrence-free survival (LRRFS), disease-free survival (DFS), overall survival (OS), and various prognostic factors. Subgroup analyses were also performed to identify patients who may benefit from PMRT.
Results
The median follow-up duration was 67 months. In ypN+ patients (n=368, 51.2%), PMRT showed significant benefits in terms of LRRFS, DFS, and OS (all p < 0.001). In multivariate analyses, histologic grade (HG) III (p=0.002), lymphovascular invasion (LVI) (p=0.045), and ypN2-3 (p=0.02) were significant risk factors for poor LRRFS. In ypN1 patients with more than two prognostic factors among luminal/human epidermal growth factor receptor-2–negative subtype, HG I-II, and absence of LVI, PMRT had no significant effect on LRRFS (p=0.18). In ypN0 patients (n=351, 48.8%), PMRT was not significantly associated with LRRFS, DFS, or OS. However, PMRT showed better LRRFS in triple-negative breast cancer (TNBC) patients (p=0.03).
Conclusion
PMRT had a major impact on treatment outcomes in patients with residual lymph nodes following NAC and mastectomy. Among ypN0 patients, PMRT may be beneficial only for those with TNBC. -
Citations
Citations to this article as recorded by
- Development and validation of an interpretable machine learning model for postoperative radiotherapy decision-making in ypN0 breast cancer after neoadjuvant chemotherapy: a real-world study
Yunjiao Zhang, Jie Duan, Niuniu Hou, Xue Zhang, Panpan Liang, Xi Chen, Chutuo Liu, Zhe Wang, Rui Ling
BMC Medical Informatics and Decision Making.2026;[Epub] CrossRef - Impact of postmastectomy radiotherapy on locoregional recurrence and survival in patients with ypN0 breast cancer after neoadjuvant chemotherapy: A comprehensive meta-analysis and systematic review
Fangjie Ding, Junfeng Zhao, Xue Wu, Xiaoman Liu, Yunxing Yang, Ying Li, Lili Qiao, Yingying Zhang
Journal of Cancer Research and Therapeutics.2025; 21(2): 477. CrossRef - Value of postmastectomy radiotherapy on overall survival in stage II–III node-negative patients following neoadjuvant therapy: A surveillance, epidemiology, and end results-based population study
Xiaoyu Wang, Xiaolin Zhao, Pian Cheng, Xiaomeng Zou, Weike Zhang, Jie Liu
Science Progress.2025;[Epub] CrossRef - A whole slide image-based risk score predicts prognosis and postmastectomy radiotherapy benefit in triple negative breast cancer patients
Hong Chen, Lizhi Zhang, Pei Liu, Luping Ji, Chuanxu Luo, Bo Peng, Ting Luo, Feng Ye, Xiaorong Zhong
Scientific Reports.2025;[Epub] CrossRef - Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline
Rachel B. Jimenez, Yara Abdou, Penny Anderson, Parul Barry, Lisa Bradfield, Julie A. Bradley, Lourdes D. Heras, Atif Khan, Cindy Matsen, Rachel Rabinovitch, Chantal Reyna, Kilian E. Salerno, Sarah E. Schellhorn, Deborah Schofield, Kekoa Taparra, Iman Wash
Annals of Surgical Oncology.2025; 32(12): 8582. CrossRef - Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline
Rachel B. Jimenez, Yara Abdou, Penny Anderson, Parul Barry, Lisa Bradfield, Julie A. Bradley, Lourdes D. Heras, Atif Khan, Cindy Matsen, Rachel Rabinovitch, Chantal Reyna, Kilian E. Salerno, Sarah E. Schellhorn, Deborah Schofield, Kekoa Taparra, Iman Wash
Journal of Clinical Oncology.2025; 43(30): 3292. CrossRef - Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline
Rachel B. Jimenez, Yara Abdou, Penny Anderson, Parul Barry, Lisa Bradfield, Julie A. Bradley, Lourdes D. Heras, Atif Khan, Cindy Matsen, Rachel Rabinovitch, Chantal Reyna, Kilian E. Salerno, Sarah E. Schellhorn, Deborah Schofield, Kekoa Taparra, Iman Wash
Practical Radiation Oncology.2025; 15(6): 549. CrossRef - A recurrence risk score model evaluating effects of postmastectomy radiotherapy in breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy: a multicenter, retrospective study
Dan-Qiong Wang, Zhou Huang, Hong-Fen Wu, Dong-Xing Shen, Hao Jing, Hui Fang, Li Zhu, Xiao-Bo Huang, Liang-Fang Shen, Mei Shi, Jia-Yi Chen, Min Liu, Jing Cheng, Ye-Xiong Li, Jian Tie, Yu Tang, Shu-Lian Wang
Therapeutic Advances in Medical Oncology.2025;[Epub] CrossRef - Analysis of Individualized Silicone Rubber Bolus Using Fan Beam Computed Tomography in Postmastectomy Radiotherapy: A Dosimetric Evaluation and Skin Acute Radiation Dermatitis Survey
Xue-mei Chen, Chen-di Xu, Li-ping Zeng, Xiao-tong Huang, Ao-qiang Chen, Lu Liu, Liu-wen Lin, Le-cheng Jia, Hua Li, Xiao-bo Jiang
Technology in Cancer Research & Treatment.2024;[Epub] CrossRef - Does Post-Mastectomy Radiotherapy Confer Survival Benefits on Patients With 1-3 Clinically Positive Lymph Nodes Rendered Pathologically Negative After Neoadjuvant Systemic Chemotherapy: Consensus from A Pooled Analysis?
Munaser Alamoodi
European Journal of Breast Health.2024; 20(2): 81. CrossRef - Oncological outcomes of stage I–II breast cancer treatment after subcutaneous/skin-sparing mastectomies with reconstruction
E. A. Rasskazova, A. D. Zikiryakhodzhaev
MD-Onco.2024; 4(3): 37. CrossRef - Effectiveness of mat pilates on fatigue in women with breast cancer submitted to adjuvant radiotherapy: randomized controlled clinical trial
Daniele Medeiros Torres, Kelly de Menezes Fireman, Erica Alves Nogueira Fabro, Luiz Claudio Santos Thuler, Rosalina Jorge Koifman, Anke Bergmann, Sabrina da Silva Santos
Supportive Care in Cancer.2023;[Epub] CrossRef - The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review
Giulia Ferrarazzo, Alberto Nieri, Emma Firpo, Andrea Rattaro, Alessandro Mignone, Flavio Guasone, Augusto Manzara, Giuseppe Perniciaro, Stefano Spinaci
Current Oncology.2023; 30(10): 8703. CrossRef
- Development and validation of an interpretable machine learning model for postoperative radiotherapy decision-making in ypN0 breast cancer after neoadjuvant chemotherapy: a real-world study
- 9,272 View
- 244 Download
- 14 Web of Science
- 13 Crossref
First
Prev
